Celiac Disease Prevention
NCT00617838 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168
Last updated 2013-08-23
Summary
Celiac disease is an autoimmune disease induced by wheat gluten. Destruction of epithelial cells and microvilli on gut mucosa is causing a "flat mucosa" and an absorption defect. The diagnosis is based on typical microscopical finding in biopsy specimens but serum antibodies to tissue transglutaminase and certain gliadin peptides are strongly associated with the pathology. Severe diarrhoea associated with growth disturbance in infancy was historically characterising the disease but is nowadays rare. Clinically more mild forms including silent disease are very common. Studies based on antibody screening and biopsies done in autoantibody positive subjects have confirmed a frequency of about 1-2% in adult population. Undiagnosed disease is associated with deficiencies of nutrients and vitamins leading to various chronic symptoms like anaemia, osteoporosis and general fatigue. It has also been recently found that undiagnosed celiac disease may be associated with general underachievement in society probably associated with common psychological symptoms like fatigue and depression during the adolescence. The disease is treated by complete elimination of wheat, rye and barley in the diet, which is laborious and causing considerable extra costs in nutrition.
Much progress has been recently made in understanding of the genetic background and immune markers associated with the disease as well as in understanding those patterns of gluten introduction in infancy, which might be connected to a high disease risk. Our aim in this study is in the first phase to identify children at high genetic risk (around 10%) and in a follow-up study to define:
1. Are the age, dose of gluten and presence of simultaneous breast feeding at the introduction of gluten associated with the risk of celiac disease?
2. Is it possible to decrease the frequency of celiac disease by nutritional counselling?
3. Is it possible to predict development of celiac disease by immunological tests before the development of mucosal lesion
If we can confirm, that optimising the conditions at the introduction of wheat gluten in infancy diet significantly reduces the disease incidence, will this have an important effect on the nutritional recommendations concerning the diet in infancy. Combining genetic screening and immunological tests might also offer a way to reduce the frequency of celiac disease and help in early diagnosis and organisation of an adequate treatment
Conditions
Interventions
- OTHER
-
Optimal gluten introduction
Optimization of gluten introduction by nutritional counselling
Sponsors & Collaborators
-
University of Eastern Finland
collaborator OTHER -
University of Turku
collaborator OTHER -
Finnish Institute for Health and Welfare
collaborator OTHER_GOV -
Päivikki and Sakari Sohlberg Foundation, Finland
collaborator OTHER -
Kätilöopisto Maternity Hospital
collaborator OTHER -
Kuopio University Hospital
lead OTHER
Principal Investigators
-
Jorma Ilonen, MD · University of Eastern Finland
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Max Age
- 2 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2014-08-31
- Completion
- 2014-12-31
Countries
- Finland
Study Locations
More Related Trials
-
Celiac Disease in Childhood-Adulthood Transition
NCT05084937 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Educational Intervention on Celiac Disease and Gluten-free Diet Through Social Networks (GLUTLEARN Project).
NCT05923346 ·Status: COMPLETED ·Phase: NA
-
Vedolizumab Induction May Prevent Celiac Enteritis
NCT02929316 ·Status: TERMINATED ·Phase: PHASE2
-
Celiac Disease: Nutrition Education in Primary School
NCT05467865 ·Status: COMPLETED ·Phase: NA
-
Supporting Children and Young People to Live Well with Coeliac Disease
NCT06007898 ·Status: COMPLETED ·Phase: NA
-
Gluten-free Oats and Gastrointestinal Health in Coeliac Disease, Part 1
NCT02764931 ·Status: COMPLETED ·Phase: NA
-
Gluten-free Diet in Gluten-genetically Predisposed Subjects
NCT00677495 ·Status: COMPLETED ·Phase: NA
-
Risk of Celiac Disease and Age at Gluten Introduction
NCT00639444 ·Status: COMPLETED ·Phase: NA
-
Serological Identification of Celiac Disease in Kids
NCT03966625 ·Status: COMPLETED
-
Mental Perfomance in Patients With Coeliac Disease
NCT06519916 ·Status: COMPLETED
-
Influence of a Gluten Free Food Guide on Diet Quality and Adherence to the GFD in Youth With Celiac Disease
NCT06038344 ·Status: COMPLETED ·Phase: NA
-
Prospective Study of Undiagnosed Celiac Disease
NCT01317914 ·Status: COMPLETED ·Phase: NA
-
Impact of the Diagnosis of Celiac Disease
NCT01145287 ·Status: COMPLETED
-
Oral AGY for Celiac Disease
NCT01765647 ·Status: COMPLETED ·Phase: PHASE1
-
Intestinal Permeability, Nutritional Status and Quality of Life in Celiac Disease
NCT04351828 ·Status: COMPLETED
-
Prevalence of Renal Disease in Children With Celiac Disease
NCT05049876 ·Status: UNKNOWN
-
Validation of a New Innovative Method for Specific Marker Detection in Celiac Disease
NCT06324539 ·Status: RECRUITING
-
Prevention of Celiac Disease in Skåne
NCT03562221 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Serum Markers in Gluten Challenge
NCT00931892 ·Status: COMPLETED ·Phase: NA
-
Support for Adolescents With Celiac Disease
NCT04533776 ·Status: COMPLETED ·Phase: NA
-
Anti-Tissue Transglutaminase IgA Antibodies
NCT04019223 ·Status: UNKNOWN
-
Evidence-based Screening Strategies for Celiac Disease
NCT03136731 ·Status: ENROLLING_BY_INVITATION
-
Infant Nutrition and Risk of Celiac Disease
NCT00819819 ·Status: TERMINATED ·Phase: NA
-
Glutenfree, Gut Microbiota and Metabolic Regulation
NCT05135923 ·Status: COMPLETED ·Phase: NA
-
Behavioral Intervention for Celiac Disease
NCT05204446 ·Status: ENROLLING_BY_INVITATION ·Phase: NA